- Previous Close
313.25 - Open
313.00 - Bid 310.00 x --
- Ask 311.90 x --
- Day's Range
304.95 - 313.00 - 52 Week Range
210.95 - 323.50 - Volume
2,811 - Avg. Volume
6,611 - Market Cap (intraday)
3.029B - Beta (5Y Monthly) 0.64
- PE Ratio (TTM)
-- - EPS (TTM)
-5.17 - Earnings Date May 26, 2025 - May 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 15, 2022
- 1y Target Est
--
Everest Organics Limited engages in the manufacture and sale of active pharmaceutical ingredients and its intermediaries in India. It is also involved in manufacturing of bulk drugs related business. The company exports its products to Europe, the United States, the Far East and the Middle East, and Latin/Central/South American countries. Everest Organics Limited was founded in 1993 and is based in Hyderabad, India.
www.everestorganicsltd.com423
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: EVERESTO.BO
View MorePerformance Overview: EVERESTO.BO
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EVERESTO.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EVERESTO.BO
View MoreValuation Measures
Market Cap
3.04B
Enterprise Value
3.55B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.49
Price/Book (mrq)
7.51
Enterprise Value/Revenue
2.07
Enterprise Value/EBITDA
51.47
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.41%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
1.72B
Net Income Avi to Common (ttm)
-41.45M
Diluted EPS (ttm)
-5.17
Balance Sheet and Cash Flow
Total Cash (mrq)
7.92M
Total Debt/Equity (mrq)
126.95%
Levered Free Cash Flow (ttm)
--